Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan Read More »
Vaccine biotech Gritstone bio is filing for bankruptcy while securing a stalking horse bid from an unnamed party, which the company hopes will save its clinical research in cancer and infectious disease.
Gritstone Files for Bankruptcy in Effort to Save Clinical Research Read More »
En la búsqueda de una apariencia más joven y fresca, la blefaroplastia se ha convertido en una tendencia tanto estéticamente atractiva como culturalmente relevante. Esta intervención quirúrgica gana popularidad entre toda la población que busca rejuvenecer s …
Dr. Cervilla, la cara visible de la Blefaroplastia en Sevilla Read More »
The overall survival data from the late-stage trial will help Pfizer in its bid to expand the label for Talzenna and Xtandi, potentially covering all patients with metastatic castration-resistant prostate cancer regardless of biomarker status.
La globalización ha transformado la forma en que se conducen las investigaciones científicas. Por esta razón, el intercambio de información y el acceso a redes colaborativas se ha hecho más fácil. Además, las plataformas digitales permiten e …
In the third episode of our mini series on artificial intelligence, Lori and guests continue their exploratory discussion on AI and the opportunity in patient lives.
The settlement, which is at the low end of Jefferies analysts’ $2 billion to $3.5 billion estimate, will resolve 93% of the product liability cases regarding allegations that GSK’s heartburn drug could cause cancer. Analysts say separate concerns remain about its vaccines business.
GSK Settles Zantac Lawsuits for $2.2B, Analysts Now Shift Focus to Vaccines Read More »
The pediatric patients, with a rare neurodegenerative disease, were treated with bluebird bio’s Skysona to slow the progression of neurologic dysfunction. Six patients developed myelodysplastic syndrome and one patient developed acute myeloid leukemia.
7 Children Receiving Bluebird’s Gene Therapy Developed Blood Cancers: Study Read More »
Carlos Doti has moved countries and changed jobs, but one thing hasn’t changed. Making an impact on patient care has always been a priority for the AstraZeneca executive.
From Argentina to America: A Physician’s Journey to Pharma and AstraZeneca Read More »
La migración celular juega un papel fundamental en multitud de procesos fisiológicos y patológicos. Los mecanismos tras este movimiento de las células están controlados por las quimioquinas, unas proteínas implicadas en el correcto funcionamiento de nuestro …
